| P/E (FY) | — | Sales (TTM) | CNY 755.7M |
| Earnings (TTM) | -CNY 19.9M | ROE | — |
| Net Margin | — | ROIC | — |
| Debt / Equity | — | TD / EBITDA | — |
| EPS Growth 3Y | — | Sales Growth 3Y | — |
| Market Cap | — | Trading Days | 542 |
| 52W High | 0.32 |
| 52W Low | 0.01 |
| % Off High | −93.34% |
| YTD | −87.17% | 1Y | −92.53% |
| Since incept. (ann.) | −62.40% |
| Ann. Volatility (1Y) | 331.64% | Ann. Volatility (3Y) | 349.84% |
| Sharpe (1Y) | 0.89 | Sharpe (3Y) | 1.33 |
| Max Drawdown (1Y) | −95.63% | Max Drawdown (3Y) | −97.88% |
| Beta (3Y, vs SPY) | −2.41 |
| Ticker | Name | Mkt cap | P/E |
|---|---|---|---|
| CON | Concentra Group Holdings Parent, Inc. | $4.18B | 25.1 |
| ACHC | Acadia Healthcare Company, Inc. | $3.01B | — |
| BACK | IMAC Holdings, Inc. | $757 | — |
| LLY | ELI LILLY & Co | $1.15T | 53.2 |
| JNJ | JOHNSON & JOHNSON | $642.79B | 24.2 |
| ONC | BeOne Medicines Ltd. | $477.60B | 1739.3 |
| ABBV | AbbVie Inc. | $465.02B | 111.5 |
| MRK | Merck & Co., Inc. | $325.57B | 18.1 |
| AMGN | AMGEN INC | $212.16B | 27.6 |
| ABT | ABBOTT LABORATORIES | $186.84B | 28.8 |
| GILD | GILEAD SCIENCES, INC. | $166.77B | 19.8 |
| PFE | PFIZER INC | $143.91B | 18.6 |
